Presentation is loading. Please wait.

Presentation is loading. Please wait.

Ceramide biosynthesis

Similar presentations


Presentation on theme: "Ceramide biosynthesis"— Presentation transcript:

1 Ceramide biosynthesis
F G H I J K L M N O P Q R 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 N S E W 8 3 6 4 1 C 746 666 478 GP1c 80 371 217 299 335 GQ1c 77 GQ1b 78 GQ1bα 94 664 GQ1aα 290 749 336 2 GT1b 97 9 294 323 344 GQ1β 761 395 365 755 653 301 302 298 Gal-GD1b 92 756 76 GT1a 79 GT1c 74 GT1aα 90 752 754 751 Fuc-GD1b 93 348 293 404 343 342 269 204 339 349 334 91 GalNAc- GD1a 308 GT1bα 324 402 305 304 328 85 341 312 482 GalNAc-GM1b 83 268 501 GD1c 130 338 774 775 75 773 GalNAc-GM1 86 345 307 780 GD1aα 88 779 96 GT2 71 303 782 KDN-GD1a 315 629 253 311 768 397 375 394 396 765 652 300 297 GD1b 73 766 GD1α 84 763 762 764 Fuc-GM1 87 657 292 GD1β 128 781 313 337 486 479 477 480 319 326 320 484 340 472 SB1a 357 GD1α2 322 321 Sialyl-Lea 327 493 481 GM1b 82 330 247 329 306 GM1 72 291 333 794 784 GM1α 127 GT3 68 GD2 70 309 387 325 316 314 310 373 374 393 295 785 473 798 783 95 786 475 408 474 485 804 210 asialo-GM1 81 GM2 69 332 805 GM2α 126 GD3 67 801 650 651 317 372 392 810 809 483 410 630 17 asialo-GM2 814 15 GM3 812 632 356 318 351 811 819 654 787 655 767 758 296 658 659 795 796 807 808 660 661 662 663 665 748 750 744 743 667 745 747 753 42 797 631 407 11 800 818 331 476 Ganglioside GD2 Ceramide biosynthesis The generic definition for a “ceramide” is an N-acyl-sphingoid base. The major sphingoid bases of mammalian sphingolipids are 18-carbon amino alkanes and alkenes derived from serine and palmitoyl-CoA, and are abbreviated by the number of hydroxyls (d for di-, t for tri-, etc.), the carbon chain length and number of bonds; for example: Sphing-4-enine sphingosine) = d18:1. In the scheme below, other sphingoid bases are designated d,tA:B to reflect variation in alkyl chain length (A) (such as d20:1 in brain gangliosides and d14:1 in insects), number of double bonds (B) (such as sphingediene, 4,14-d18:2 in mammals & 4,8-d18:2 in plants) and number of hydroxyl groups (such as 4-hydroxysphinganine, phytosphingosine, 4t18:0, and 6-hydroxysphingosine, 6-t18:1, in skin). Other variations include sidechain methylation and the presence of triple bonds. The rest of Sphingomap shows possible headgroups that are added to these lipid backbones. Ceramides & 4-Hydroxydihydroceramides (Phytoceramides) Dihydroceramides & Other Homologs Other sphingoid bases & fatty acids d,tA;B; Cx:y d18:0; 16:0 d18:1; 20:0 t18:0; 18:0 22:0 24:1 24:0 26:1 26:0 Yeast Phytoceramide “Ceramides” are N-acyl-sphingoid bases. The fatty acids are designated by Cx:y to reflect chain length (x), double bonds (y), and other modifications (e.g. α-hydroxy, αh-, not shown). Other fatty acid variations include ω-hydroxylation (in skin). Sphingosine-1P Phosphoethanolamine 3-Ketosphinganine L-serine Stearoyl-CoA or other fatty acyl-CoA’s 4-Hydroxysphinganine Sphingosine (d18:1) Sphinganine (d18:0) Sphinganine-1P Palmitoyl-CoA + or Gal-series 3 GM4 13 1 C GalCer 5 CDG 9 4 Gala-series SM4s 16 Arthro-series Glc-series GlcCer 2 6 10 Mollu-series 14 356 SM3 LacCer 17 asialo-GM2 15 GM3 11 iGb3 7 pk antigen 12 nLc4Cer 8 Ganglio-series Globo-series IsoGlobo-series Lacto-series NeoLacto-series Phosphosphingolipids Phospho-series 630 IsoGanglio-series 632 Muco-series Non-mammalian (Phosphono-) (Arseno-) Ceramide phosphate Sphingomyelin (Ceramide phosphocholine) Cer-O-P(O2H)-O-CH2CH2N(CH3)3 Sphingosyl-phosphocholine Phytoceramide phosphoinositol(s) Phytoceramide phosphoinositol-phosphate & other derivatives Ceramide ciliatine Ceramide arsenocholine Ceramide phosphoethanolamine Sulfatide Nomenclature for classification of glycosphingolipids Root name Carbohydrate in the ‘root’ structure (Abbrev) IV III II I Ganglio (Gg) Lacto (Lc) Neolacto (nLc) Globo (Gb) Isoglobo (iGb) Mollu (Mu) Arthro (At) Galβ1–3GalNacβ1–4Galβ1–4Glcβ1-Cer Galβ1–3GlcNacβ1–3Galβ1–4Glcβ1-Cer Galβ1–4GlcNacβ1–3Galβ1–4Glcβ1-Cer GalNacβ1–3Galα1–4Galβ1–4Glcβ1-Cer GalNacβ1–3Galα1–3Galβ1–4Glcβ1-Cer GalNacβ1–2Manα1–3Manβ1–4Glcβ1-Cer GalNacβ1–4GlcNacβ1–3Manβ1–4Glcβ1-Cer 1. Merrill AH Jr, Wang MD, Park M, Sullards MC (2007) (Glyco)Sphingolipidology: an amazing challenge and opportunity for systems biology, Trends Biochem. Sci. 32: 2. Yu RK, Yanagisawa M, Ariga T (2007) Glycosphingolipid structures in Comprehensive Glycoscience, Four-Volume Set, Volume 1-4: from Chemistry to Systems Biology by J. P. Kamerling, Editor-in-Chief, Elsevier, Amsterdam. 3. Suzuki, A. (2003) Map 3. Biosynthetic pathways of glycosphingolipids in Handbook of Glycosyltransferases and Related Genes (N. Taniguchi, K. Honke, and M. Fukuda, eds) Springer (Tokyo), pp 4.KEGG Sphingophospholipid biosynthesis: 5. KEGG Sphingolycolipid metabolism: 6. Lipid Bank for Web Database: 7. Nomenclature from “Essentials of Glycobiology”as modified for 2nd. Edition: and The Consortium for Functional Glycomics, Prepared by: Meeyoung Park, Hyejung Park, Anu Koppikar, Akemi Suzuki, Alfred H. Merrill, Jr. and others in the Georgia Tech Sphingolipid Research Lab ( School of Biology & Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology in affiliation with the Lipid Maps Consortium & the UGA Complex Carbohydrate Research Center. Assistance with web design and maintenance: Rebecca Lee Acknowledgements We thank the following for suggestions: Eoin Fahy, Tony Futerman, Kentaro Hanada, Sen-itiroh Hakomori, Yoshio Hirabayashi, Jin-Young Hong, Michael “Hawkeye” Pierce, Konrad Sandhoff, Ronald L. Schnaar, Walt Shaw (Avanti Polar Lipids), M. Cameron Sullards, C. C. Sweeley, Elaine Wang and May Dongmei Wang And the following for support: the Lipid MAPS Consortium (GM69338, Ed Dennis, PI), the Smithgall Institute Endowment for Molecular Cell Biology and the Petit Institute for Bioengineering & Bioscience at Georgia Tech, and the UGA Integrated Technology Resource for Biomedical Glycomics (PA , Michael Pierce, PI). Version 2.0 10/15/07 SphinGOMAP.orgGlyco/Ontologies/Metabolonics Ganglioside GD1a Galactose (Gal) N-acetylgalactosamine (GalNAc) Glucose (Glc) N-acetylglucosamine (GlcNAc) Mannose (Man) N-acetylmannosamine (ManNAc) Fucose Xylose Neuraminic Acid (Neu5Ac) N-Glycoloyl-Neu (NeuGc) KDN,(+)-3-deoxy-D-glycero-D-galacto-2-nonulosonic acid Glucuronyl (GlcU) Sphingosine SO4 NeuNH2 HSO3 Ac-O GlcNH2 Ceramide 1.The numbers within the symbols represent the carbon connectivity 2. Underlined numbers have alpha (α) linkage 3. Plain numbers have beta (β) linkage S *SphinGOMAP is an evolving pathway map for sphingolipid biosynthesis that includes many of the known sphingolipids and glycosphingolipids arranged according to their biosynthetic steps [1-7] or, in the cases where the biosynthetic enzymes have not yet been identified, in hypothetical pathways. It is hoped that this pathway will promote dialog about the “knowns” and “unknowns” of sphingolipid biosynthesis and lead to experiments to refine this model. Users may print or modify the map for personal use if the source is appropriately acknowledged; for other uses, or to recommend corrections or additions, contact Dr. Al Merrill at (please refer to the version of SphinGOMAP and the compounds by molecule number and map coordinates). C U Documented Molecule* Undocumented Molecule Molecule Number (SM ID) Documented Pathway* Undocumented Pathway *See notes in box 1 C 1 C 2 Ganglio-series SphinGOMAP.org A B C D E F G H I J K L M N O P Q R


Download ppt "Ceramide biosynthesis"

Similar presentations


Ads by Google